D
Denali Therapeutics
DNLI · NASDAQ · Healthcare
$24.74
+$0.01 (+0.04%) today
Loading live data...
Market Cap
$3.93B
24h Volume
$31.9M
P/E Ratio
-7.6
52w High
$27.21
52w Low
$12.75
Est. AI Revenue
15%
Loading chart data...
7-Day Sparkline (Static)
About Denali Therapeutics
Biotechnology company using AI/ML for drug discovery targeting neurodegenerative diseases including Alzheimer's and Parkinson's.
CEO: Ryan Watts
Founded: 2013
HQ: South San Francisco, California
Employees: 507
Performance
24 Hours+0.04%
7 Days+7.47%
30 Days-9.08%
1 Year+73.86%